Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implication. [electronic resource]
Producer: 20140829Description: 589-99 p. digitalISSN:- 1938-2723
- Anticoagulants -- pharmacology
- Benzimidazoles -- pharmacology
- Blood Coagulation Factors -- antagonists & inhibitors
- Dabigatran
- Electrophoresis, Polyacrylamide Gel
- Factor Xa -- metabolism
- Factor Xa Inhibitors
- Humans
- Morpholines -- pharmacology
- Prothrombin -- antagonists & inhibitors
- Pyrazoles -- pharmacology
- Pyridones -- pharmacology
- Rivaroxaban
- Thiophenes -- pharmacology
- Thrombin -- biosynthesis
- Thromboplastin -- metabolism
- beta-Alanine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.